These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25560007)

  • 1. Contribution of efflux pumps in fluroquinolone resistance in multi-drug resistant nosocomial isolates of Pseudomanas aeruginosa from a tertiary referral hospital in north east India.
    Choudhury D; Talukdar AD; Maurya AP; Choudhury MD; Dhar Chanda D; Chakravarty A; Bhattacharjee A
    Indian J Med Microbiol; 2015; 33(1):84-6. PubMed ID: 25560007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India.
    Choudhury D; Ghose A; Dhar Chanda D; Das Talukdar A; Dutta Choudhury M; Paul D; Maurya AP; Chakravarty A; Bhattacharjee A
    PLoS One; 2016; 11(2):e0149156. PubMed ID: 26866484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M
    J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
    Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA.
    Azimi L; Namvar AE; Jamali S; Lari AR; Bijari A; Lari AR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):86-90. PubMed ID: 27328522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
    Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
    J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor.
    Adabi M; Talebi-Taher M; Arbabi L; Afshar M; Fathizadeh S; Minaeian S; Moghadam-Maragheh N; Majidpour A
    Infect Chemother; 2015 Jun; 47(2):98-104. PubMed ID: 26157587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit.
    Ozer B; Duran N; Onlen Y; Savas L
    J Antibiot (Tokyo); 2012 Jan; 65(1):9-13. PubMed ID: 22086166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ; Smith-Moland E; Goering RV; Hanson ND; Lister PD
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran.
    Bijari A; Azimi L; Fallah F; Ardebili A; Lari ER; Lari AR
    Infect Disord Drug Targets; 2016; 16(3):172-177. PubMed ID: 27572250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Prevalence of Metallo-β-Lactamases and Efflux-Mediated Mechanisms in Carbapenem Nonsusceptible Nosocomial Pseudomonas aeruginosa Isolated in Moscow in 2012-2015].
    Vestn Ross Akad Med Nauk; 2015; (6):679-83. PubMed ID: 27093795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.
    Pasca MR; Dalla Valle C; De Jesus Lopes Ribeiro AL; Buroni S; Papaleo MC; Bazzini S; Udine C; Incandela ML; Daffara S; Fani R; Riccardi G; Marone P
    Microb Drug Resist; 2012 Feb; 18(1):23-32. PubMed ID: 21797666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of chlorogenic acid and carnosol for anti-efflux pump and anti-biofilm activities against extensively drug-resistant strains of
    Sheikhy M; Karbasizade V; Ghanadian M; Fazeli H
    Microbiol Spectr; 2024 Sep; 12(9):e0393423. PubMed ID: 39046262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    Sonnet P; Izard D; Mullié C
    Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
    Chien JY; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2017 Sep; 50(3):491-495. PubMed ID: 28668684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India.
    Ellappan K; Belgode Narasimha H; Kumar S
    J Glob Antimicrob Resist; 2018 Mar; 12():37-43. PubMed ID: 28893647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa.
    Dunham SA; McPherson CJ; Miller AA
    Eur J Clin Microbiol Infect Dis; 2010 Mar; 29(3):279-88. PubMed ID: 20099021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.